Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
baicalein | arachidonate 5-lipoxygenase | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | lactoylglutathione lyase | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | prolyl endopeptidase | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | l-selectin | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | p-selectin | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | tumor necrosis factor | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
baicalein | xanthine dehydrogenase/oxidase | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Orthomyxoviridae Infections[MeSHID:D009976] |
NA | phase 2 | unknown |
click here to return to the previous page |